tetano
Editor, Senior Moderator
Lancet
. 2022 Mar 5;399(10328):890-893.
doi: 10.1016/S0140-6736(22)00379-8.
Prioritise research on vaccines for pregnant and breastfeeding women
Terra Manca[SUP] 1 [/SUP], Françoise Baylis[SUP] 2 [/SUP], Flor M Munoz[SUP] 3 [/SUP], Karina A Top[SUP] 4 [/SUP]
Affiliations
No abstract available
Conflict of interest statement
KAT has received grants from GlaxoSmithKline to her institution for work related to vaccines that could be given to pregnant women. FMM is a member of the Data and Safety Monitoring Boards for vaccines manufactured by Pfizer (respiratory syncytial virus [RSV]), Moderna (RSV, human metapneumovirus, parainfluenza, SARS-CoV-2, influenza), Virometix (RSV), and Meissa (RSV vaccines). FMM is an investigator in research supported by Pfizer (SARS-CoV-2 vaccines), Gilead (remdesivir), the US National Institutes of Health (safety of vaccines in pregnancy, Zika virus), and the US Centers for Disease Control and Prevention (respiratory virus epidemiology) for work directly or indirectly related to vaccines that could be given to pregnant women. TM has received funding from an IWK Health Centre postdoctoral fellowship grant and is funded by the Public Health Agency of Canada and Canadian Institutes of Health Research through a Canadian Immunization Research Network postdoctoral grant. FB declares no competing interests.
. 2022 Mar 5;399(10328):890-893.
doi: 10.1016/S0140-6736(22)00379-8.
Prioritise research on vaccines for pregnant and breastfeeding women
Terra Manca[SUP] 1 [/SUP], Françoise Baylis[SUP] 2 [/SUP], Flor M Munoz[SUP] 3 [/SUP], Karina A Top[SUP] 4 [/SUP]
Affiliations
- PMID: 35248174
- DOI: 10.1016/S0140-6736(22)00379-8
No abstract available
Conflict of interest statement
KAT has received grants from GlaxoSmithKline to her institution for work related to vaccines that could be given to pregnant women. FMM is a member of the Data and Safety Monitoring Boards for vaccines manufactured by Pfizer (respiratory syncytial virus [RSV]), Moderna (RSV, human metapneumovirus, parainfluenza, SARS-CoV-2, influenza), Virometix (RSV), and Meissa (RSV vaccines). FMM is an investigator in research supported by Pfizer (SARS-CoV-2 vaccines), Gilead (remdesivir), the US National Institutes of Health (safety of vaccines in pregnancy, Zika virus), and the US Centers for Disease Control and Prevention (respiratory virus epidemiology) for work directly or indirectly related to vaccines that could be given to pregnant women. TM has received funding from an IWK Health Centre postdoctoral fellowship grant and is funded by the Public Health Agency of Canada and Canadian Institutes of Health Research through a Canadian Immunization Research Network postdoctoral grant. FB declares no competing interests.